Quantcast
Channel: MS Trust Blog » drugs
Browsing latest articles
Browse All 6 View Live

The right to treatment

We recently launched a webcast about drug therapies here on our website, it features several clips of Professor David Bates, Consultant Neurologist at University of Newcastle-upon-Tyne NHS Hospitals...

View Article



Mark up on private prescriptions

With access to NHS prescriptions of Sativex difficult in many parts of the country, a number of people have been asking for private prescriptions. This has highlighted the issue of different pharmacies...

View Article

Image may be NSFW.
Clik here to view.

Walking back to happiness?

Walking. It’s such a significant ability, isn’t it? Being able to walk is one of the markers of development from babyhood to childhood. And to many of the general population in our culture, it’s...

View Article

Image may be NSFW.
Clik here to view.

In development, licensed and approved; the confusing world of MS Drugs

In my day to day work I spend a lot of time of Facebook and Twitter, I post news articles and pick up on questions people might have for the MS Trust. I notice a lot of people (including myself) get...

View Article

NICE or a nasty tangle? Four potential new drugs, NICE, licensing, and ‘best...

Four new disease modifying drugs for relapsing/remitting MS are currently going through appraisal at NICE. These are: Teriflunomide (Aubagio) – factsheet BG-12 also known as dimethyl fumarate...

View Article


Anti-LINGO-1, biotin and phenytoin results reported at AAN 2015

The 67th annual meeting of the American Academy of Neurology took place in Washington, April 18-25.  Pre-meeting media announcements created high expectations for several presentations at the meeting,...

View Article
Browsing latest articles
Browse All 6 View Live




Latest Images